Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q04DX003 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
72.0 |
Antitumor endpoint evaluated on day 16; 06/06 animals surviving on day 16 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
86.0 |
Antitumor endpoint evaluated on day 16; 06/06 animals surviving on day 16 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
75.0 |
Antitumor endpoint evaluated on day 16; 06/06 animals surviving on day 16 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
33.0 |
Antitumor endpoint evaluated on day 16; 06/06 animals surviving on day 16 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
40.0 |
Antitumor endpoint evaluated on day 16; 06/06 animals surviving on day 16 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
29.0 |
Antitumor endpoint evaluated on day 16; 06/06 animals surviving on day 16 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 16; 01/06 animals surviving on day 16 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 16; 00/06 animals surviving on day 16 |